These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31102258)

  • 1. Computational design and optimization of novel d-peptide TNFα inhibitors.
    Yang W; Zhang Q; Zhang C; Guo A; Wang Y; You H; Zhang X; Lai L
    FEBS Lett; 2019 Jun; 593(12):1292-1302. PubMed ID: 31102258
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Computational design of helical peptides targeting TNFα.
    Zhang C; Shen Q; Tang B; Lai L
    Angew Chem Int Ed Engl; 2013 Oct; 52(42):11059-62. PubMed ID: 24038781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of potent mimic peptide derived from monoclonal antibody: antibody mimic design.
    Feng J; Li Y; Zhang W; Shen B
    Immunol Lett; 2005 May; 98(2):311-6. PubMed ID: 15860233
    [TBL] [Abstract][Full Text] [Related]  

  • 4. De novo designed transmembrane peptides activating the α5β1 integrin.
    Mravic M; Hu H; Lu Z; Bennett JS; Sanders CR; Orr AW; DeGrado WF
    Protein Eng Des Sel; 2018 May; 31(5):181-190. PubMed ID: 29992271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening bicyclic peptide libraries for protein-protein interaction inhibitors: discovery of a tumor necrosis factor-α antagonist.
    Lian W; Upadhyaya P; Rhodes CA; Liu Y; Pei D
    J Am Chem Soc; 2013 Aug; 135(32):11990-5. PubMed ID: 23865589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective targeting of MAPK family kinases JNK over p38 by rationally designed peptides as potential therapeutics for neurological disorders and epilepsy.
    Zhuo ZH; Sun YZ; Jin PN; Li FY; Zhang YL; Wang HL
    Mol Biosyst; 2016 Jul; 12(8):2532-40. PubMed ID: 27263470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A novel human scFv fragment against TNF-alpha from de novo design method.
    Chang H; Qin W; Li Y; Zhang J; Lin Z; Lv M; Sun Y; Feng J; Shen B
    Mol Immunol; 2007 Jul; 44(15):3789-96. PubMed ID: 17485112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithm to design inhibitors using stereochemically mixed l,d polypeptides: Validation against HIV protease.
    Gupta P; Durani S
    Int J Biol Macromol; 2015 Nov; 81():410-7. PubMed ID: 26279121
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proposing novel TNFα direct inhibitor Scaffolds using fragment-docking based e-pharmacophore modeling and binary QSAR-based virtual screening protocols pipeline.
    Zaka M; Abbasi BH; Durdagi S
    J Mol Graph Model; 2018 Oct; 85():111-121. PubMed ID: 30149308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding modes of Bcl-2 homology 3 (BH3) peptides with anti-apoptotic protein A1 and redesign of peptide inhibitors: a computational study.
    Chen Y; Wang J; Zhang J; Wang W
    J Biomol Struct Dyn; 2018 Nov; 36(15):3967-3977. PubMed ID: 29137527
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico identification and design of potent peptide inhibitors against PDZ-3 domain of Postsynaptic Density Protein (PSD-95).
    Sharma T; Siddiqi MI
    J Biomol Struct Dyn; 2019 Mar; 37(5):1241-1253. PubMed ID: 29557723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De novo design TNF-alpha antagonistic peptide based on the complex structure of TNF-alpha with its neutralizing monoclonal antibody Z12.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    J Biotechnol; 2006 Aug; 125(1):57-63. PubMed ID: 16522339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel domain antibody rationally designed against TNF-alpha using variable region of human heavy chain antibody as scaffolds to display antagonistic peptides.
    Qin W; Feng J; Li Y; Lin Z; Shen B
    Mol Immunol; 2007 Mar; 44(9):2355-61. PubMed ID: 17125837
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Designing helical peptide inhibitors of protein-protein interactions.
    Rezaei Araghi R; Keating AE
    Curr Opin Struct Biol; 2016 Aug; 39():27-38. PubMed ID: 27123812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening of tumor necrosis factor-alpha-binding peptides by phage display peptide library.
    Guo HP; Luo HB; Liu YJ; Zhu P; Fu N
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):597-9. PubMed ID: 12376284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design of inhibitors of Ras--Raf interaction using a computational combinatorial algorithm.
    Zeng J; Nheu T; Zorzet A; Catimel B; Nice E; Maruta H; Burgess AW; Treutlein HR
    Protein Eng; 2001 Jan; 14(1):39-45. PubMed ID: 11287677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. (alpha/beta+alpha)-peptide antagonists of BH3 domain/Bcl-x(L) recognition: toward general strategies for foldamer-based inhibition of protein-protein interactions.
    Sadowsky JD; Fairlie WD; Hadley EB; Lee HS; Umezawa N; Nikolovska-Coleska Z; Wang S; Huang DC; Tomita Y; Gellman SH
    J Am Chem Soc; 2007 Jan; 129(1):139-54. PubMed ID: 17199293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of anti-TNFalpha peptides with consensus sequence.
    Zhang J; Zheng L; Zhao A; Gao B; Liu NL; Wang F; Dong J; Xin ZT; Shao NS; Wang HX; Xue YN
    Biochem Biophys Res Commun; 2003 Oct; 310(4):1181-7. PubMed ID: 14559240
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PRO_LIGAND: an approach to de novo molecular design. 6. Flexible fitting in the design of peptides.
    Murray CW; Clark DE; Byrne DG
    J Comput Aided Mol Des; 1995 Oct; 9(5):381-95. PubMed ID: 8594156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor Necrosis Factor-α Trimer Disassembly and Inactivation via Peptide-Small Molecule Synergy.
    Checco JW; Eddinger GA; Rettko NJ; Chartier AR; Gellman SH
    ACS Chem Biol; 2020 Aug; 15(8):2116-2124. PubMed ID: 32662976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.